Sensitization at the first wheezing episode increases risk for long-term asthma therapy

Pediatric Allergy and Immunology

Volumn 26, Issue 7, 2015, Pages 687-691

  Lukkarinen, Minna ^a   Vuorinen, Tytti ^a   Lehtinen, Pasi ^a   Ruuskanen, Olli ^a   Jartti, Tuomas ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FOOD ALLERGEN; IMMUNOGLOBULIN E; PREDNISOLONE; ALLERGEN; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER;

ASTHMA; BRONCHIOLITIS; CHILD; CRACKLE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; ECZEMA; EOSINOPHIL COUNT; FOLLOW UP; FOOD ALLERGY; HIGH RISK PATIENT; HUMAN; LETTER; LONG TERM CARE; MEDICATION COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOVIRUS INFECTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIZATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WHEEZING; BLOOD; COMPLICATION; FEMALE; FOOD HYPERSENSITIVITY; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; RESPIRATORY SOUNDS;

ADRENAL CORTEX HORMONES; ALLERGENS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMARKERS; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; INFANT; MALE; RESPIRATORY SOUNDS; RISK FACTORS;

EID: 84944161578     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12439     Document Type: Letter

References (12)

1. National Asthma Education and Protection Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007: 120: S94-138.
2. Midulla F, Pierangeli A, Cangiano G, et al. Rhinovirus bronchiolitis and recurrent wheezing: one year follow-up. Eur Respir J 2012: 39: 396-402.
3. Lukkarinen M, Lukkarinen H, Lehtinen P, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7-year follow-up. Pediatr Allergy Immunol 2013: 24: 237-43.
4. Jartti T, Nieminen R, Vuorinen T, et al. Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. J Allergy Clin Immunol 2015: 135: 691-8.
5. Turunen R, Koistinen A, Vuorinen T, et al. The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol 2014: 25: 796-803.
6. Marguet C, Lubrano M, Gueudin M, et al. In very young infants severity of acute bronchiolitis depends on carried viruses. PLoS ONE 2009: 4: e4596.
7. Flores P, Guimaraes J, Videira Amaral JM. Th1 and th2 cytokine expression in nasopharyngeal secretions during acute bronchiolitis in children younger than two years old. Allergol Immunopathol (Madr) 2011: 39: 3-9.
8. Kusel MM, Kebadze T, Johnston SL, Holt PG, Sly PD. Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J 2012: 39: 876-82.
9. Koster ES, Wijga AH, Zuidgeest MG, et al. Patterns of asthma medication use: early asthma therapy initiation and asthma outcomes at age 8. Pharmacoepidemiol Drug Saf 2010: 19: 991-9.
10. Zuidgeest MG, Smit HA, Bracke M, et al. Persistence of asthma medication use in preschool children. Respir Med 2008: 102: 1446-51.
11. Baris S, Karakoc-Aydiner E, Ozen A, Ozdemir C, Bahceciler NN, Barlan IB. Serum immunoglobulin levels as a predictive factor for a better outcome of non-atopic childhood asthma. Pediatr Allergy Immunol 2011: 22: 298-304.
12. Nissen SP, Kjaer HF, Host A, Nielsen J, Halken S. The natural course of sensitization and allergic diseases from childhood to adulthood. Pediatr Allergy Immunol 2013: 24: 549-55.